Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Xiaodong 1. Wang | Director | 2025-01-07 | 41,760 | $6.50 | $271.44kBuy |
Xiaodong 1. Wang | Director | 2025-01-07 | 1,301 | $179.19 | $233.12kSell |
Xiaodong 1. Wang | Director | 2025-01-07 | 11,310 | $176.67 | $2.00MSell |
Xiaodong 1. Wang | Director | 2025-01-07 | 19,251 | $175.46 | $3.38MSell |
Xiaodong 1. Wang | Director | 2025-01-07 | 5,638 | $178.39 | $1.01MSell |
Xiaodong 1. Wang | Director | 2025-01-07 | 4,260 | $177.42 | $755.81kSell |
John Oyler | Chief Executive Officer | 2024-12-14 | 1,300,000 | $0.50 | $650.00kBuy |
Xiaodong 1. Wang | Director | 2024-12-10 | 725 | $194.01 | $140.66kSell |
Xiaodong 1. Wang | Director | 2024-12-10 | 300 | $195.67 | $58.70kSell |
Xiaodong 1. Wang | Director | 2024-12-10 | 1,374 | $192.61 | $264.64kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Hillhouse Capital Advisors Ltd | 10.61% | 147,035,258 | $32.68B | Insider |
Hhlr Advisors Ltd | 9.02% | 125,045,741 | $27.79B | Insider |
Hillhouse Capital Management Ltd | 8.00% | 110,866,146 | $24.64B | Insider |
Cb Biotech Investment Ltd | 1.41% | 19,601,138 | $4.36B | Insider |
Amgen Inc | 1.37% | 18,943,802 | $4.21B | Insider |
Baker Bros Advisors LP | 0.76% | 10,568,897 | $2.35B | Institution |
Merck Co Inc | 0.57% | 7,942,314 | $1.77B | Insider |
Capital International Investors | 0.46% | 6,430,884 | $1.43B | Institution |
Xiaodong Wang | 0.40% | 5,491,395 | $1.22B | Insider |
Xiaodong 1. Wang | 0.38% | 5,240,932 | $1.16B | Insider |